Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Nov 04, 2021 8:41pm
86 Views
Post# 34089860

RE:RE:4th Quarter

RE:RE:4th Quarter
Year3000 wrote:

I'm running out of patience which Replicel. They said they had a dermal sized package under the Christmas tree 2 years ago and it's still not here. Delay after delay. 

I feel I have a little fuel left in the tank but I'll be running on fumes soon. Ive invested in the stock over the past 5 years and could have put the money in Tesla instead. 

My first child was born 2 weeks ago and I could frankly do with the money. 

I invested in company because I was passionate about what they could achieve, I'm not sure how much longer I can hold on for. :(

Any words of encouragement appreciated 

 



Congratulations on the birth of your first child.

Year3000 I feel your pain. It has been a very disappointing 5 years for me as well.  I thought this year we would finally see the rewards we deserved as long suffering shareholders but as we move into this 4th Quarter we hear the SOS.  They will not be able to kick the can down the road for much longer as the AGM will be at the end of the month and the will surely receive some harsh feedback from the shareholders.

<< Previous
Bullboard Posts
Next >>